Lehne's Pharmacology for Nursing Care 9th Edition by Jacqueline Burchum
Lehne's Pharmacology for Nursing Care 9th Edition by Jacqueline Burchum
$2.99
Chapter 101: Basic Principles of Cancer Chemotherapy
Complete Chapter Questions With Answers
Sample Questions Are Posted Below
MULTIPLE CHOICE
| a. | “The patient’s reluctance about the doses administered.” |
| b. | “The patient’s degree of nausea.” |
| c. | “The toxicity of anticancer drugs to normal tissues.” |
| d. | “The difficulty attaining and maintaining venous access.” |
ANS: C
The major obstacle to successful chemotherapy is the toxicity of anticancer drugs to normal tissues. The patient’s reluctance regarding the dose is a vague response. The patient’s degree of nausea should not be an issue, because many good antiemetics may be given prophylactically. The question does not address whether the chemotherapy is administered PO or IV; therefore, the response regarding venous access would be an assumption.
PTS: 1 DIF: Cognitive Level: Comprehension REF: p. 1206
TOP: Nursing Process: Evaluation
MSC: NCLEX Client Needs Category: Physiologic Integrity: Pharmacologic and Parenteral Therapies
| a. | “Cancer cells are characterized by unrestrained growth and division.” |
| b. | “Division of cancer cells is characteristically rapid.” |
| c. | “Malignant cells of solid tumors do not invade other tissues.” |
| d. | “Telomerase is an enzyme produced by cancer cells that promotes metastases.” |
ANS: A
Because malignant cells are unresponsive to the feedback mechanisms that regulate cellular proliferation in healthy tissue, they are characterized by unrestrained growth and division. Division of tumor cells is not necessarily rapid. Malignant cells of all types can metastasize. Telomerase is an enzyme that permits repeated division of cancer cells.
PTS: 1 DIF: Cognitive Level: Analysis REF: pp. 1207-1208
TOP: Nursing Process: Evaluation
MSC: NCLEX Client Needs Category: Physiologic Integrity: Physiologic Adaptation
| a. | that hospitalization is necessary to provide infection prophylaxis. |
| b. | that the provider will probably repeat the lab work in 3 to 5 days. |
| c. | to ask the provider about skipping the next dose of chemotherapy. |
| d. | to report any symptoms such as pus, abscesses, or cough. |
ANS: B
Normal neutrophil counts range from 2500 to 7000 cells/mm3. The lowest neutrophil count, or nadir, usually occurs 10 to 14 days after dosing, so this patient’s neutrophil count should be repeated at that time. Hospitalization is controversial because of the risk of exposure to serious infections. The next dose should not be skipped unless the neutrophil count is below 500/mm3. Patients with neutropenia may not have symptoms of pus, abscess, or cough and should be instructed to report any fever.
PTS: 1 DIF: Cognitive Level: Application REF: pp. 1214-1215
TOP: Nursing Process: Assessment
MSC: NCLEX Client Needs Category: Physiologic Integrity: Physiologic Adaptation
| a. | “Cells in this patient’s type of tumor will proliferate rapidly.” |
| b. | “Chemotherapeutic agents that are not toxic to other tissues may be used.” |
| c. | “This type of tumor is especially sensitive to chemotherapy.” |
| d. | “This tumor will be managed primarily with surgery.” |
ANS: D
Cells in the G0 phase are mitotically dormant; tumors composed mostly of G0 cells have low growth fractions. Because cytotoxic agents are more active against tumors with high growth fraction, this patient’s type of tumor will be managed primarily by surgery and not chemotherapy. Cells in this type of tumor do not proliferate rapidly.
PTS: 1 DIF: Cognitive Level: Application REF: pp. 1208-1209
TOP: Nursing Process: Planning
MSC: NCLEX Client Needs Category: Physiologic Integrity: Physiologic Adaptation
Original price was: $30.00.$20.00Current price is: $20.00.
Original price was: $39.99.$19.99Current price is: $19.99.
Original price was: $100.00.$75.00Current price is: $75.00.
Original price was: $25.00.$15.00Current price is: $15.00.
Original price was: $30.00.$20.00Current price is: $20.00.
